ORIC
ORIC Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +11.1% ·
aandelenstroom +26.5% ·
netto nieuwe posities +10.0%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | 0 | 59.02M | $639.12M | +7 | −7 |
| Q1 2026 | 75 | +3 | 50.35M | $637.44M | +9 | −6 |
| Q4 2025 | 72 | +1 | 55.15M | $451.14M | +1 | — |
| Q3 2025 | 17 | 0 | 34.78M | $417.41M | — | — |
| Q2 2025 | 14 | +1 | 27.12M | $275.30M | +3 | −2 |
| Q1 2025 | 10 | +1 | 12.33M | $68.78M | +2 | −1 |
| Q4 2024 | 9 | -1 | 9.74M | $78.61M | — | −1 |
| Q3 2024 | 9 | 0 | 7.63M | $78.26M | +1 | −1 |
| Q2 2024 | 9 | — | 8.42M | $59.53M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 6.57M | +48.3% | $36.68M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passief) | 2.20M | +19.0% | $12.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.33M | +2.9% | $7.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.33M | +2.9% | $7.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 1.31M | +2.1% | $7.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 1.31M | +2.1% | $7.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 511.89K | +1305.3% | $2.86M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 178.22K | -4.4% | $994,451 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 178.22K | -4.4% | $994,451 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 76.99K | -44.9% | $429,604 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Millennium Management ✦ | 53.98K | +95.3% | $301,225 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 49.53K | Nieuw | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 49.53K | Nieuw | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 49.53K | Nieuw | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 49.53K | Nieuw | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 49.53K | Nieuw | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 47.70K | Nieuw | $266,138 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| AQR Capital Management | $276,376 | 0.0% |
| AQR Capital Management | $276,376 | 0.0% |
| AQR Capital Management | $276,376 | 0.0% |
| AQR Capital Management | $276,376 | 0.0% |
| AQR Capital Management | $276,376 | 0.0% |
| Marshall Wace | $266,138 | 0.0% |
Verlaten
| Adage Capital Partners | $4.04M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 181 houders, 119.04M aandelen, $1.43B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.